Cencora COR | NYSE

$227.69 $1.42 | 0.63%

After Hours
$230.91 $3.22 | 1.41%

Next Earnings: Jan 29, 2025

Company Overview:

Market Cap: $44.01B
PE Ratio: 30.2
52-Week Range: $202.26 - $253.27
Dividend Yield (FWD): 0.97% ($2.20)

10 Year Performance Metrics:

Total Return (with DRIP): 187.11% (11.12% / yr)
Total Return (no DRIP): 165.71% (10.27% / yr)
Share Price: 147.65%
Dividend Increase: 89.66%
COR 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

COR Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
COR Dividend CAGR:1Y: 7.84%2Y: 6.49%5Y: 6.58%10Y: 6.61%
Share Price
COR Price CAGR:1Y: 13.96%2Y: 16.63%5Y: 21.59%10Y: 9.52%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

COR Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - COR
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - COR
14-Day FREE Trial Get Full Access Now!

COR Earnings, Revenue, Cash & Debt, Shares Outstaning:

COR - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
COR - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
COR - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
COR - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
COR - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
COR - Cash & Debt
14-Day FREE Trial Get Full Access Now!
COR - Revenue
14-Day FREE Trial Get Full Access Now!
COR Revenue CAGR:1Y: 14.69%2Y: 13.68%5Y: 11.61%10Y: 9.61%
COR - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
COR EPS CAGR:1Y: -99.01%2Y: -88.95%5Y: -48.46%10Y: -23.21%
COR - Net Income
14-Day FREE Trial Get Full Access Now!
COR Net Income CAGR:1Y: -99.04%2Y: -89.29%5Y: -27.98%10Y: -4.27%
COR - EBITDA
14-Day FREE Trial Get Full Access Now!
COR EBITDA CAGR:1Y: -52.45%2Y: -22.33%5Y: 44.11%10Y: 31.64%
COR - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
COR Free Cash Flow CAGR:1Y: -50.46%2Y: -9.14%5Y: 6.63%10Y: 0.67%
COR - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
COR Free Cash Flow / Share CAGR:1Y: -49.18%2Y: -6.07%5Y: 7.88%10Y: 2.45%
COR - Gross Profit
14-Day FREE Trial Get Full Access Now!
COR Gross Profit CAGR:1Y: 10.60%2Y: 11.69%5Y: 16.10%10Y: 11.07%
COR - Expenses
14-Day FREE Trial Get Full Access Now!
COR Expenses CAGR:1Y: 3.89%2Y: 2.49%5Y: 18.07%10Y: 10.73%
COR - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
COR Shares Outstanding CAGR:1Y: -2.61%2Y: -2.87%5Y: 39.77%10Y: 24.74%
COR - Share Buybacks
14-Day FREE Trial Get Full Access Now!
COR Share Buybacks CAGR:1Y: 84.63%2Y: 46.50%5Y: 27.27%10Y: 10.66%
COR - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
COR Stock-Based Comp CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
COR - Dividends
14-Day FREE Trial Get Full Access Now!
COR Dividend CAGR:1Y: 7.84%2Y: 6.49%5Y: 6.58%10Y: 6.61%
COR - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
COR Revenue CAGR:1Y: 14.69%2Y: 13.68%5Y: 11.61%10Y: 9.61%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

COR - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
COR Actual Revenue CAGR:1Y: 14.69%2Y: 13.68%5Y: 11.61%10Y: 9.61%
COR - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
COR Actual EPS CAGR:1Y: -99.01%2Y: -88.95%5Y: -48.46%10Y: -23.21%
COR - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
COR Actual Net Income CAGR:1Y: -99.04%2Y: -89.29%5Y: -27.98%10Y: -4.27%
COR - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
COR Actual EBITDA CAGR:1Y: -52.45%2Y: -22.33%5Y: 44.11%10Y: 31.64%

Ratios, Profit Margins & Return on Capital:

COR - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
COR Net Profit Margin CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
COR - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
COR Gross Profit Margin CAGR:1Y: -3.67%2Y: -1.85%5Y: 3.99%10Y: 1.33%
COR - Price to Earnings
14-Day FREE Trial Get Full Access Now!
COR - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
COR - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
COR - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

COR Dividends Info:

Annual Dividend: $2.20
Forward Yield: 0.97%
Ex-Dividend Date: 2024-11-15
Lifetime Dividens / Share: $21.31

COR Dividend History: Dates, Payments & Yield list

Below is a schedule of all COR dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
11/15/202411/29/2024$0.5500.87%0.92%$240.24
08/09/202408/26/2024$0.5100.86%0.86%$237.77
05/09/202405/24/2024$0.5100.9%0.91%$224.09
02/08/202402/26/2024$0.5100.86%0.89%$230.32
11/10/202311/27/2023$0.5100.99%1.03%$197.57
08/10/202308/28/2023$0.4851.04%1.04%$187.03
05/11/202305/30/2023$0.4851.12%1.13%$171.44
02/09/202302/27/2023$0.4851.22%1.25%$155.02
11/10/202211/28/2022$0.4851.2%1.25%$155.00
08/12/202208/29/2022$0.4601.22%1.22%$150.50
05/13/202205/31/2022$0.4601.19%1.2%$152.89
02/11/202202/28/2022$0.4601.28%1.31%$140.24
11/12/202110/15/2021$0.4601.42%1.47%$125.34
08/13/202107/15/2021$0.4401.47%1.47%$119.57
05/14/202104/15/2021$0.4401.49%1.51%$116.52
02/11/202101/15/2021$0.4401.65%1.68%$104.53
11/13/202010/15/2020$0.4401.57%1.63%$108.12
08/14/202007/15/2020$0.4201.6%1.62%$103.75
05/15/202004/15/2020$0.4201.91%1.96%$85.75
02/13/202001/15/2020$0.4201.71%1.78%$94.52
11/15/201912/02/2019$0.4001.83%1.83%$87.30
08/16/201910/15/2019$0.4001.83%1.83%$87.34
05/17/201907/15/2019$0.4002.03%2.06%$77.73
02/15/201904/15/2019$0.4001.8%1.85%$86.66
11/16/201801/15/2019$0.4001.74%1.8%$88.75
08/17/201810/15/2018$0.3801.73%1.73%$87.72
05/18/201807/16/2018$0.3801.78%1.79%$84.77
02/16/201804/16/2018$0.3801.5%1.53%$99.40
11/17/201701/16/2018$0.3801.87%1.93%$78.84
08/17/201710/16/2017$0.3651.83%1.83%$79.94
05/18/201707/17/2017$0.3651.66%1.68%$86.69
02/16/201704/17/2017$0.3651.56%1.62%$90.32
11/17/201601/17/2017$0.3651.73%1.82%$80.16
08/18/201610/17/2016$0.3401.53%1.53%$88.97
05/19/201607/15/2016$0.3401.75%1.81%$75.05
02/18/201604/15/2016$0.3401.45%1.57%$86.69
11/12/201510/15/2015$0.3401.25%1.4%$96.91
08/13/201509/01/2015$0.2901.12%1.12%$103.88
05/14/201507/15/2015$0.2900.96%1.01%$114.66
02/12/201501/15/2015$0.2901.05%1.16%$99.83
11/13/201412/01/2014$0.2901.12%1.3%$89.08
08/14/201410/15/2014$0.2351.23%1.23%$76.62
05/15/201407/15/2014$0.2351.36%1.39%$67.50
02/13/201404/15/2014$0.2351.31%1.38%$67.89
11/14/201301/15/2014$0.2351.25%1.36%$69.22
08/15/201310/15/2013$0.2101.47%1.47%$57.27
05/16/201307/15/2013$0.2101.4%1.54%$54.40
02/13/201304/15/2013$0.2101.46%1.8%$46.64
11/15/201201/15/2013$0.2101.49%2.09%$40.16
08/17/201210/15/2012$0.1301.39%1.39%$37.54
05/17/201207/16/2012$0.1301.39%1.43%$36.44
02/15/201204/16/2012$0.1301.33%1.42%$36.71
11/17/201101/17/2012$0.1301.31%1.39%$37.52
08/18/201110/17/2011$0.1151.3%1.22%$37.69
05/20/201107/15/2011$0.1151.09%1.11%$41.59
02/16/201104/15/2011$0.1301.15%1.43%$36.37
11/18/201001/14/2011$0.1301.18%1.65%$31.44
08/20/201008/25/2010$0.0801.11%1.11%$28.92
05/20/201005/24/2010$0.0800.98%1.04%$30.68
02/10/201002/12/2010$0.0800.99%1.18%$27.19
11/19/200911/23/2009$0.0800.99%1.32%$24.21
08/20/200908/24/2009$0.0601%1.14%$21.00
05/14/200905/18/2009$0.0501.05%1.12%$17.86
02/12/200902/16/2009$0.0500.92%1.06%$18.92
11/20/200811/24/2008$0.0501.18%1.46%$13.74
08/14/200808/18/2008$0.0380.71%0.71%$21.09
05/15/200805/19/2008$0.0380.67%0.73%$20.51
02/13/200802/15/2008$0.0383.6%0.68%$22.17
11/15/200711/19/2007$0.0383.54%0.68%$22.18
08/16/200708/20/2007$0.0253.48%0.45%$22.20
08/01/200708/03/2007$0.6993.35%12.11%$23.08
05/17/200705/21/2007$0.0250.34%0.39%$25.40
02/23/200702/28/2007$0.0250.27%0.36%$27.50
11/16/200611/20/2006$0.0250.26%0.42%$23.68
08/17/200608/21/2006$0.0130.23%0.23%$21.79
05/18/200605/22/2006$0.0130.2%0.23%$21.83
02/15/200602/17/2006$0.0130.17%0.23%$21.96
11/22/200511/24/2005$0.0130.16%0.25%$19.81
08/18/200508/22/2005$0.0060.14%0.14%$18.17
05/19/200505/23/2005$0.0060.15%0.15%$16.51
02/16/200502/18/2005$0.0060.16%0.16%$15.31
11/18/200411/22/2004$0.0060.17%0.17%$14.54
08/19/200408/23/2004$0.0060.19%0.19%$13.13
05/14/200405/19/2004$0.0060.17%0.17%$14.74
02/11/200402/13/2004$0.0060.18%0.18%$14.25
11/13/200311/17/2003$0.0060.15%0.15%$16.24
08/14/200308/18/2003$0.0060.16%0.16%$15.43
05/15/200305/19/2003$0.0060.16%0.16%$15.20
02/12/200302/14/2003$0.0060.18%0.18%$13.70
11/14/200211/18/2002$0.0060.16%0.16%$15.95
08/15/200208/19/2002$0.0060.14%0.14%$17.33
05/16/200205/20/2002$0.0060.1%0.13%$19.01
02/19/200202/21/2002$0.0060.08%0.16%$15.88
11/15/200111/19/2001$0.0060.05%0.18%$13.86

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for COR

Based on past 10-year performance, here are COR growth metrics:

Share price CAGR of +9.49%
Dividend CAGR of +6.61%
Using COR CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

COR
Current Price$227.69
Start Shares43.92
Start Value$10,000
 
After 10 years:
Final Share Count47.86
Dividends Payment$1.04
Annual Dividends$200
Yield on cost2.00%
Share Price$514.99
Total Dividends$1,376
Final Value$24,646

Estimated Future Value + Dividends - COR

NOTE: Above numbers are our estimate based on COR's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Cencora (COR) had its IPO on 1995-04-04, and is trader on NYSE stock exchange.

Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

COR website: https://www.amerisourcebergen.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial